脑脊液中的抗人类免疫缺陷病毒抗体:早期治疗影响中枢神经系统病毒库的证据?
研究检测慢性感染(n=10)和早期感染(n=12)患者长期治疗前后脑脊液与血清中的HIV抗体,并对比未治疗早期感染(n=10)。慢性感染治疗逾10年抑制性ART后抗体仅小幅下降;早期启动ART较慢性长期治疗使脑脊液抗体降低43倍(P>.0001)、血抗体降低7倍(P=.0003)。
要点
- 慢性感染长期抑制性ART逾10年,脑脊液和血清抗HIV抗体仅小幅下降。
- 未治疗早期感染中血抗体第30天出现,脑脊液抗体约2周后达相似水平。
- 早期ART较慢性长期治疗使脑脊液抗体降低43倍(P>.0001)、血抗体降低7倍(P=.0003)。
核心结论
- 若脑脊液与血抗体差异提示HIV持续存在,数据表明中枢神经系统病毒库建立相对晚于系统性病毒库,为早期治疗更大程度影响长期中枢神经系统感染提供机会。
研究设计与样本
- 在慢性感染(n=10)和早期感染(n=12)长期治疗前后,以及未治疗早期感染(n=10)中,检测配对脑脊液和血清中的HIV抗体。
主要发现
- 慢性感染治疗尽管抑制性ART逾10年,脑脊液和血清抗HIV抗体仅小幅下降。
- 未治疗早期感染中,血抗HIV抗体第30天出现,脑脊液抗体约2周后达相似水平。
- 早期ART较慢性感染长期治疗使脑脊液抗体降低43倍(P>.0001),血抗体降低7倍(P=.0003)。
- 两名暴露前预防后早期ART者脑脊液和血均未产生抗体,柏林患者脑脊液抗体显著降低。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite effective antiretroviral therapy (ART), human immunodeficiency virus (HIV) likely persists in the central nervous system (CNS) in treated individuals. We examined anti-HIV antibodies in cerebrospinal fluid (CSF) and blood as markers of persistence. METHODS: Human immunodeficiency virus antibodies were measured in paired CSF and serum before and after long-term treatment of chronic (n = 10) and early infection (n = 12), along with untreated early infection (n = 10). RESULTS: Treatment of chronic infection resulted in small reductions of anti-HIV antibodies in CSF and serum despite >10 years of suppressive ART. In untreated early infection, anti-HIV antibodies emerged in blood by day 30, whereas CSF antibodies reached similar levels 2 weeks later. Compared with long-term treatment of chronic infection, early ART initiation reduced CSF antibodies by 43-fold (P > .0001) and blood antibodies by 7-fold (P = .0003). Two individuals receiving pre-exposure prophylaxis and then ART early after infection failed to develop antibodies in CSF or blood, whereas CSF antibodies were markedly reduced in the Berlin patient. CONCLUSIONS: To the extent that differential CSF and blood antibodies indicate HIV persistence, these data suggest a relative delay in establishment of the CNS compared with the systemic HIV reservoir that provides an opportunity for early treatment to have a greater impact on the magnitude of long-term CNS infection.
引用
- Burbelo PD, Price RW, Hagberg L, et al. Anti-Human Immunodeficiency Virus Antibodies in the Cerebrospinal Fluid: Evidence of Early Treatment Impact on Central Nervous System Reservoir? J Infect Dis. 2018. PMID: 29401308. doi:10.1093/infdis/jix662
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。